From drug and device discovery and development to regulatory approval, drug reimbursement to lifecycle management – you need to make smart decisions that give you an advantage in a fast changing market.
The pharma and healthcare sector is facing unparalleled upheaval: increasing pressures on research and development teams to show a better return on investment, difficulty keeping abreast of complex regulatory and pricing and reimbursement environments and the race to get the best deal in a competitive business development arena. Informa’s Pharma Intelligence is the trusted partner of all of the top 50 global pharmaceutical companies and the top 10 contract research organisations (CRO’s) – providing timely intelligence and insight to make authoritative decisions.
Our connected team of journalists, researchers and analysts are based in key markets around the globe. Drawing on a foundation of high quality proprietary data you can trust that the insights gained through our solutions have the level of precision needed to make forward focused decisions with confidence.
The pharma and healthcare sector is facing unparalleled upheaval: increasing pressures on research and development teams to show a better return on investment, difficulty keeping abreast of complex regulatory and pricing and reimbursement environments and the race to get the best deal in a competitive business development arena. Informa’s Pharma Intelligence is the trusted partner of all of the top 50 global pharmaceutical companies and the top 10 contract research organisations (CRO’s) – providing timely intelligence and insight to make authoritative decisions.
Our connected team of journalists, researchers and analysts are based in key markets around the globe. Drawing on a foundation of high quality proprietary data you can trust that the insights gained through our solutions have the level of precision needed to make forward focused decisions with confidence.
Location: United States, New York
Employees: 1001-5000
Investors 1
| Date | Name | Website |
| 18.06.2022 | Warburg Pi... | warburgpin... |
Mentions in press and media 22
| Date | Title | Description |
| 26.09.2025 | Citeline Launches AI Importer to Optimize Global Clinical Trial Disclosure Workflows | New artificial intelligence capability in TrialScope Disclose streamlines protocol processing, reduces manual effort, and empowers sponsors to bring work in-house a global leader in clinical trial intelligence and technology solutions, anno... |
| 01.02.2023 | World’s leading clinical intelligence company acquires Clinerion | |
| 01.12.2022 | Citeline Announces Winners of the 2022 Scrip Awards, Recognizing Accomplishments in Healthcare | LONDON (PRWEB) December 01, 2022 At a live ceremony held Wednesday night in London, Citeline announced the winners of the annual Scrip Awards, recognizing the outstanding accomplishments of those improving human healthcare worldwide. Now in... |
| 20.10.2022 | Citeline Connect-Savvy Cooperative Partnership Provides Patient Insights to Optimize Clinical Trial Websites | NEW YORK (PRWEB) October 20, 2022 Citeline Connect, an end-to-end clinical trial engagement and recruitment solution, seeking to incorporate the patient voice during the design stage of custom clinical trial websites, partners with Savvy Co... |
| 13.09.2022 | CPhI and Pharma Intelligence Announce 2022 Editions of Pharma IPR India and Biopharma Conclave in Mumbai | Mumbai, Maharashtra, India Pharma Intelligence, now Citeline, one of the leading business intelligence providers and knowledge partners, is pleased to announce the 11th Pharma IPR India 2022, and the 4th edition of Biopharma Conclave 2022 o... |
| 14.06.2022 | The irony — and ignominy — of medical conferences as superspreader events | Emergency physicians like us have seen the worst of Covid-19, from children gasping for breath to death on an unimaginable scale. So you might expect us to be cautious about attending large public gatherings and set a standard by establishi... |
| 13.04.2022 | Incentives to spur repurposing of existing generics for novel uses would open a new paradigm in drug R&D | The Drug Price Competition and Patent Term Restoration Act of 1984, better known as the Hatch-Waxman Act, which enabled the regulatory process for generic drugs, has been remarkably successful. Generic drugs now represent about 90% of presc... |
| 11.02.2022 | OpenSea illustrates the perils of growing too fast | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Hi Term Sheet readers. Fortune finance editor Lee Clifford here filling for in Jessica Mathews to... |
| 11.02.2022 | OpenSea illustrates the perils of growing too fast | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Hi Term Sheet readers. Fortune finance editor Lee Clifford here filling for in Jessica Mathews to... |
| 13.10.2021 | Informa Pharma Intelligence Partners with ICON to Launch an Integrated Predictive Analytic Solution for Clinical Trial Feasibility | Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, announced its partnership with ICON plc, one of the world’s leading contract research organizations (CROs), to elevate its cutting-edge, pred... |
Show more